Trial platform matches cancer patients to clinical care
Using apps and AI technology, Belong.Life brings together cancer patients and current clinical research projects, to further development of therapies.
Using apps and AI technology, Belong.Life brings together cancer patients and current clinical research projects, to further development of therapies.
The UK-based collaboration will include expertise across more than 40 types of cancer, with access to patients from more than 170 referring oncologists.
The $800K grant will fund development of therapeutics for infectious diseases, including respiratory viruses like COVID-19, using machine learning.